Heart Health
Bempedoic Acid Cuts Venous Clot Risk by 42% in Statin-Intolerant Patients
A post hoc analysis of the CLEAR Outcomes trial finds bempedoic acid significantly reduces DVT and pulmonary embolism risk.
Research Paper
May 29, 2026 0
Results for "Bempedoic Acid"
20 articles
Longevity & Aging
Bempedoic Acid Found Safe Enough to Allow Breastfeeding to Continue
New guidance suggests mothers taking bempedoic acid for cholesterol need not stop breastfeeding, though caution is advised for newborns.
Research Paper
Jun 7, 2026 0
Heart Health
Bempedoic Acid Plus Ezetimibe Combo Targets LDL in Diabetic Patients
A Phase 2 trial tests whether a fixed-dose combination pill can safely lower LDL cholesterol in people with type 2 diabetes.
Clinical Trial
Jun 17, 2026 0
Metabolic Health
Cholesterol Drug Bempedoic Acid Activates Key Fat-Burning Pathway in Liver Cells
New research reveals how the cholesterol medication bempedoic acid directly activates PPARα, boosting fat metabolism beyond its known effects.
Research Paper
Mar 29, 2026 3
Longevity & Aging
BHB Supplement Shields Brain from Damage Caused by Saturated Fat Diets
Beta-hydroxybutyrate restores AMPA receptor function and prevents memory loss triggered by saturated fat-rich diets in mice.
Research Paper
May 31, 2026 0
Brain Health
Fatty Acid Molecule Erucamide Halts Retinal Degeneration in Mice
A naturally occurring fatty acid amide activates immune cells in the retina, protecting neurons and blood vessels from degenerative damage.
Research Paper
Jun 21, 2026 0
Brain Health
BACE Inhibitor Atabecestat Trial in Pre-Symptomatic Alzheimer's Risk Terminated Early
A phase 2/3 trial of the BACE inhibitor atabecestat in amyloid-positive asymptomatic adults was terminated before completion, raising questions about this drug class.
Clinical Trial
May 13, 2026 0
Longevity & Aging
FDA Approves First-in-Class Blood Pressure Pill That Targets Aldosterone at the Source
Baxdrostat blocks aldosterone production directly, cutting systolic BP by ~15 mmHg in resistant hypertension patients who failed other drugs.
Press Release
May 19, 2026 0
Metabolic Health
FDA Approves Baxfendy, a New Aldosterone Synthase Inhibitor for Hypertension
Baxdrostat becomes the first-in-class aldosterone synthase inhibitor approved to treat resistant hypertension alongside existing drugs.
Drug Approval
May 19, 2026 0
Longevity & Aging
Plant Compound Epiberberine Tames Gut Inflammation by Fixing Bile Acid Recycling
A natural alkaloid from traditional Chinese medicine activates a key bile acid receptor to restore intestinal balance and reduce colitis inflammation.
Research Paper
Jun 4, 2026 0
Longevity & Aging
BPC 157 Peptide Controls Angiogenesis and Nitric Oxide for Broad Healing Benefits
A comprehensive review argues that BPC 157's effects on angiogenesis and nitric oxide are therapeutic assets, not risks, with anti-tumor and neuroprotective evidence.
Research Paper
May 31, 2026 0
Brain Health
Herbal Compound Clears Alzheimer's Plaques by Activating AMPK Autophagy Pathway
A traditional Chinese herbal formula improves cognition and cerebrovascular health in Alzheimer's mice by activating the LKB1-AMPK-SIRT1 autophagy cascade.
Research Paper
May 21, 2026 0
Longevity & Aging
BPC 157 Defends Against Cancer and Neurodegeneration by Mastering Angiogenesis and Nitric Oxide
Researchers rebut claims that BPC 157 promotes tumor growth or neurodegeneration, citing evidence it modulates—not dysregulates—angiogenesis and NO.
Research Paper
May 18, 2026 0
Longevity & Aging
FDA Approves First Aldosterone Synthase Inhibitor BAXFENDY to Tackle Resistant Hypertension
AstraZeneca's BAXFENDY cuts systolic blood pressure by nearly 10 mmHg beyond placebo in adults whose BP wasn't controlled by other drugs.
Press Release
May 20, 2026 0
Longevity & Aging
Methylene Blue Cuts Postoperative Delirium by Calming Brain Inflammation
FDA-approved methylene blue reduced delirium-like behavior in surgical mice by suppressing neuroinflammation and repairing the blood-brain barrier.
Research Paper
May 18, 2026 0
Longevity & Aging
Berberine Shields the Liver While Boosting Evodiamine's Colitis-Fighting Power
Combining two traditional herbal compounds fixes a dangerous liver toxicity problem while making colitis treatment significantly more effective.
Research Paper
Jun 6, 2026 0
Longevity & Aging
NACET Compound Activates Cellular Defense Against Age-Related Eye Disease
Modified antioxidant shows promise for preventing diabetic retinopathy and macular degeneration by boosting cellular protection.
Research Paper
Apr 19, 2026 0
Brain Health
New Alzheimer's Drug BMS-984923 Completes Safety Testing in 51 Participants
Phase 1b trial tests escalating doses of experimental Alzheimer's treatment BMS-984923 for safety and tolerability in older adults.
Clinical Trial
Mar 28, 2026 1
Longevity & Aging
Methylene Blue Emerges as a Versatile Clinical Tool Beyond Emergency Medicine
A comprehensive review reveals methylene blue's expanding role from toxicology emergencies to perioperative care, neurology, and oncology.
Research Paper
May 13, 2026 0
Brain Health
Retired Cholesterol Drug Shows Promise for Alzheimer's Prevention in Small Trial
Probucol, a discontinued cholesterol medication, may boost brain-protective proteins in older adults at risk for dementia.
Clinical Trial
Mar 29, 2026 0
Page 1 of 2Next